Exon-1 polymorphism of ctla-4 gene is not associated with systemic sclerosis in Iranian patients

被引:8
作者
Rajaee, A.
Ebrahimi, A.
Ghiam, A. Fotouhi
Kalantari, T.
Ghaderi, A.
机构
[1] Shiraz Univ Med Sci, Dept Immunol, Sch Med, Shiraz, Iran
[2] Shiraz Univ Med Sci, Dept Rheumatol, Shiraz, Iran
[3] Shiraz Univ Med Sci, Shiraz Inst Canc Res, Shiraz, Iran
关键词
systemic sclerosis; polymorphism; CTLA-4;
D O I
10.1007/s00296-005-0047-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although, the cytotoxic T lymphocyte antigen-4 gene polymorphism at position 49 of exon-1 has been strongly elucidated in different autoimmune diseases, but its role in predisposition to systemic sclerosis (SSc) is yet controversial. This study intends to analyze the genetic correlation of the ctla-4 gene locus with diffuse systemic sclerosis (dSSc), as well as to understand the influence of these genotypes in disease expression. Seventy known cases of SSc, and 151 age-matched healthy controls, were participated in this investigation. The frequencies of AA, GG and AG genotypes were found to be 26 (37.1%), 5 (7.2%) and 39 (55.7%) in patients, and 60 (39.7%), 19 (12.6%) and 72 (47.7%) in controls, respectively. As indicated, the differences in genotype and allele frequencies between patients and controls were insignificant (P > 0.05). Moreover, the distribution of CTLA-4 polymorphism between patients did not differ significantly according to clinical and serologic features. In Iranian patients, susceptibility to SSc is not influenced by a bi-allelic ctla-4 gene (A49G) polymorphism.
引用
收藏
页码:687 / 692
页数:6
相关论文
共 31 条
[1]   Increased expression levels of integrin αvβ5 on scleroderma fibroblasts [J].
Asano, Y ;
Ihn, H ;
Yamane, K ;
Kubo, M ;
Tamaki, K .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (04) :1275-1292
[2]   Impaired Smad7-Smurf-mediated negative regulation of TGF-β signaling in scleroderma fibroblasts [J].
Asano, Y ;
Ihn, H ;
Yamane, K ;
Kubo, M ;
Tamaki, K .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (02) :253-264
[3]   The role of chemokines in the pathogenesis of scleroderma [J].
Atamas, SP ;
White, B .
CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (06) :772-777
[4]  
Bachleitner-Hofmann T, 2002, CLIN EXP RHEUMATOL, V20, P85
[5]   Cytotoxic T lymphocyte antigen-4 gene polymorphisms do not confer susceptibility to autoimmune hepatitis types 1 and 2 in Brazil [J].
Bittencourt, PL ;
Palácios, SA ;
Cançado, ELR ;
Porta, G ;
Carrilho, FJ ;
Laudanna, AA ;
Kalil, J ;
Goldberg, AC .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (07) :1616-1620
[6]   CTLA-4 and its role in autoimmune thyroid disease [J].
Chistiakov, DA ;
Turakulov, RI .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2003, 31 (01) :21-36
[7]   Antibodies in scleroderma: direct pathogenicity and phenotypic associations. [J].
Chung L. ;
Utz P.J. .
Current Rheumatology Reports, 2004, 6 (2) :156-163
[8]   Diffuse scleroderma occurring after the use of paclitaxel for ovarian cancer [J].
De Angelis, R ;
Bugatti, L ;
Cerioni, A ;
Del Medico, P ;
Filosa, G .
CLINICAL RHEUMATOLOGY, 2003, 22 (01) :49-52
[9]   Systemic sclerosis: current views of its pathogenesis [J].
Derk, CT ;
Jimenez, SA .
AUTOIMMUNITY REVIEWS, 2003, 2 (04) :181-191
[10]   Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease [J].
Donner, H ;
Braun, J ;
Seidl, C ;
Rau, H ;
Finke, R ;
Ventz, M ;
Walfish, PG ;
Usadel, KH ;
Badenhoop, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (12) :4130-4132